Intersect ENT (XENT) Misses Q3 EPS by 2c, Maintains Guidance
Tweet Send to a Friend
Intersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.41), $0.02 worse than the analyst estimate of ($0.39). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
